Table 2 Patient and disease characteristics at entrance into BRASS cohort for subjects with ≥2 years of follow-up, in remission at one or more visit to any remission definition, and not in remission at entrance
From: Sustained rheumatoid arthritis remission is uncommon in clinical practice
N= 394 | n(%)/Median (IQR) |
|---|---|
Female | 320 (81) |
Age (years) | 56 (45-63) |
Positive anti-CCP or RF status | 282 (72) |
Smoking | 24 (6) |
Disease duration (years) | 8 (2-19) |
Any stiffness | 286 (73) |
Stiffness duration (minutes) | 30-60 (10-90) |
CRP (mg/L) | 2.7 (1.1-7.9) |
NSAIDs | 244 (62) |
Corticosteroids | 103 (26) |
MTX | 196 (50) |
Nonbiologic DMARDs (not MTX) | 137 (35) |
Biologics | 133 (34) |